LazyNews
NORMAL
Markets

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage - CNBC

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Share:
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. Novo Nordisk on Su… [+7026 chars]

Community

Comments

Share your perspective. Thoughtful contributions make LazyNews useful.

0 comments

Log in to join the discussion.

Loading comments…